News
Brüssel – Die Europäische Arzneimittelagentur ( EMA) empfiehlt nun doch die Zulassung des Alzheimerantikörpers Donanemab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback